Martin Behe Selected Research

Intravenous Injections

1/2022

A Multispecific Anti-CD40 DARPin Construct Induces Tumor-Selective CD40 Activation and Tumor Regression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Behe Research Topics

Disease

22	Neoplasms (Cancer) 04/2024 - 09/2006
3	Thyroid Neoplasms (Thyroid Cancer) 04/2024 - 01/2016
2	Insulinoma 05/2019 - 06/2007
2	Glioblastoma (Glioblastoma Multiforme) 01/2016 - 06/2012
2	Necrosis 06/2012 - 06/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 05/2019
1	Glioma (Gliomas) 01/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2013
1	Thrombosis (Thrombus) 03/2011
1	Carotid Artery Thrombosis 03/2011
1	Prostatic Neoplasms (Prostate Cancer) 01/2011
1	Neoplasm Metastasis (Metastasis) 12/2010
1	Xerostomia 09/2010
1	Cognitive Dysfunction 01/2009
1	Alzheimer Disease (Alzheimer's Disease) 01/2009
1	Carcinogenesis 06/2007
1	Capsule Opacification 05/2006
1	Cataract (Cataracts) 05/2006

Drug/Important Bio-Agent (IBA)

5	Cholecystokinin B ReceptorIBA 04/2024 - 05/2014
5	Radioisotopes (Radionuclides)IBA 02/2024 - 01/2016
5	minigastrinIBA 01/2022 - 05/2014
4	Peptides (Polypeptides)IBA 11/2022 - 03/2012
3	LigandsIBA 12/2022 - 03/2011
2	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2024 - 09/2011
2	Mechanistic Target of Rapamycin Complex 1IBA 12/2022 - 01/2020
2	Fibronectins (Fibronectin)IBA 11/2022 - 11/2020
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	IntegrinsIBA 01/2022 - 04/2013
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2020
2	PeptidomimeticsIBA 01/2020 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2016
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2020 - 01/2011
2	Glucagon-Like Peptide-1 ReceptorIBA 05/2019 - 06/2007
2	Exenatide (Byetta)FDA Link 05/2019 - 06/2007
2	EpitopesIBA 02/2014 - 03/2011
1	sacubitrilIBA 04/2024
1	Neprilysin (Neutral Endopeptidase)IBA 04/2024
1	TOR Serine-Threonine KinasesIBA 12/2022
1	Bacterial AdhesinsIBA 11/2022
1	Designed Ankyrin Repeat ProteinsIBA 01/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022
1	CytokinesIBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	AmidesIBA 01/2020
1	TriazolesIBA 01/2020
1	alanyltyrosineIBA 01/2020
1	SolutionsIBA 01/2020
1	Everolimus FDA Link 01/2020
1	succinylated gelatinIBA 01/2020
1	aspartyl-phenylalanine (aspartylphenylalanine)IBA 01/2020
1	Peptide Receptors (Peptide Receptor)IBA 01/2020
1	glycyltryptophanIBA 01/2020
1	CGP 57380IBA 01/2016
1	cercosporamideIBA 01/2016
1	Temozolomide (Temodar)FDA LinkGeneric 01/2016
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2016
1	Eukaryotic Initiation Factor-4EIBA 01/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2014
1	Terbium-155IBA 05/2014
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 05/2014
1	Aligeron (AS 2)IBA 02/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2012
1	vadimezanIBA 06/2012
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2012
1	GastrinsIBA 03/2012
1	Cholecystokinin (Pancreozymin)IBA 03/2012
1	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 03/2012
1	Monoclonal AntibodiesIBA 01/2011
1	AntibodiesIBA 12/2010
1	AC133 AntigenIBA 12/2010
1	Amyloid beta-PeptidesIBA 01/2009
1	AutoantibodiesIBA 01/2009
1	Amyloid (Amyloid Fibrils)IBA 01/2009
1	Therapeutic UsesIBA 06/2007
1	RadiopharmaceuticalsIBA 06/2007
1	Pentetic Acid (DTPA)FDA LinkGeneric 06/2007
1	Glucagon-Like Peptide 1 (GLP 1)IBA 06/2007
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2006
1	Trastuzumab (Herceptin)FDA Link 09/2006
1	PolyethyleneimineIBA 09/2006
1	PolymersIBA 05/2006

Therapy/Procedure

12	Therapeutics 02/2024 - 06/2007
4	Radiotherapy 01/2022 - 06/2007
1	Premedication 04/2024
1	Molecular Targeted Therapy 12/2022
1	Immunotherapy 01/2022
1	Intravenous Injections 01/2022
1	Injections 01/2020
1	Drug Therapy (Chemotherapy) 01/2016
1	Adjuvant Chemotherapy 01/2016
1	Transcutaneous Electric Nerve Stimulation (TENS) 05/2006
1	Intraocular Lenses (Intraocular Lens) 05/2006